Reprocell USA, a subsidiary of Japan’s Reprocell Inc., and Fox Chase Ltd., one of the Fox Chase Cancer Center organizations, formed a joint venture to operate a multi-site bio-sample repository facility in India.
Initial operations are underway in Delhi with plans to expand to Hyderabad later this year. The facilities will add approximately 3,000 new bio-samples monthly. Collected specimens will be supported by annotations that include medical history, mutation data and detailed records of treatment protocols as well as outcomes.
